(NASDAQ: FLGC) Flora Growth's forecast annual revenue growth rate of -3.27% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 118.05%.
Flora Growth's revenue in 2025 is $52,373,000.On average, 1 Wall Street analysts forecast FLGC's revenue for 2025 to be $29,316,081, with the lowest FLGC revenue forecast at $29,316,081, and the highest FLGC revenue forecast at $29,316,081.
In 2026, FLGC is forecast to generate $32,388,888 in revenue, with the lowest revenue forecast at $32,388,888 and the highest revenue forecast at $32,388,888.